Related references
Note: Only part of the references are listed.Pregnancy outcomes decline with increasing recipient body mass index: an analysis of 22,317 fresh donor/recipient cycles from the 2008-2010 Society for Assisted Reproductive Technology Clinic Outcome Reporting System registry
Meredith P. Provost et al.
FERTILITY AND STERILITY (2016)
The value of HCG serum concentrations after trigger in predicting pregnancy and live birth rates in IVF-ICSI
Jianjun Zhou et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2015)
Pharmacokinetics of Human Chorionic Gonadotropin Injection in Obese and Normal-Weight Women
Divya K. Shah et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
The effect of delayed initiation of gonadotropin-releasing hormone antagonist in a flexible protocol on in vitro fertilization outcome
Samer Tannus et al.
FERTILITY AND STERILITY (2013)
Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles
C. A. Venetis et al.
HUMAN REPRODUCTION UPDATE (2013)
Human chorionic gonadotropin (hCG) plasma levels at oocyte retrieval and IVF outcomes
R. Matorras et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2012)
Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis
Vivian Rittenberg et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2011)
Human chorionic gonadotropin: A hormone with immunological and angiogenic properties
Marie Tsampalas et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2010)
Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient's body mass index and the number of larger follicles
Laura Detti et al.
FERTILITY AND STERILITY (2007)
Relationship between serum human chorionic gonadotrophin levels and body mass index in women undergoing in vitro fertilisation cycles
Petros Stefanis et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2007)
Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization
BS Shapiro et al.
FERTILITY AND STERILITY (2005)
A prospective, randomized, double-blind study to compare two doses of recombinant human chorionic gonadotropin in inducing final oocyte maturity and the hormonal profile during the luteal phase
CCW Chan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Bioavailability of hCG after intramuscular or subcutaneous injection in obese and non-obese women
CCW Chan et al.
HUMAN REPRODUCTION (2003)
Use of recombinant human chorionic gonadotropin in ovulation induction
M Ludwig et al.
FERTILITY AND STERILITY (2003)
Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization - embryo transfer
A Weissman et al.
FERTILITY AND STERILITY (2003)
Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle
JR Stelling et al.
FERTILITY AND STERILITY (2003)
Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology:: Results of a clinical trial comparing two doses of rhCG (Ovidrel®) to urinary hCG (Profasi®) for induction of final follicular maturation in in vitro fertilization-embryo transfer
P Chang et al.
FERTILITY AND STERILITY (2001)
Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization-embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection
KE Elkind-Hirsch et al.
FERTILITY AND STERILITY (2001)
Share Paper
